Anne Parneix, MD

Anne Parneix, MD
Senior Global Program Head
Novartis Pharmaceuticals Corporation

Anne Parneix earned her MD and Board Certification in Dermatology with subspecialty in Infectious Diseases from Paris University. Her in-hospital clinics focused on serious skin diseases such as Kaposi’s Sarcoma in HIV patients. As she wanted to make a greater difference for patients, she turned her attention to research. As a result, she is currently working at Novartis Pharmaceuticals Corporation, where she is a Vice President and Senior Global Program Head, leading global teams in charge of bringing new therapies to patients.
​
Anne entered Novartis in 2003 as an Associate Director working on a new molecular entity for the treatment of Atopic Dermatitis and Psoriasis. She then joined the Global Development Organization where she held positions of increasing responsibility as Director and Executive Director on various programs in Immunology, Dermatology and Infectious Diseases. Prior to being a Senior Global Program Head, in her role of Therapeutic Area Head, she was responsible for driving clinical excellence, establishing disease area strategy, managing the internal portfolio, and supervising in-licensing activities for Dermatology.

Prior to joining Novartis, Anne headed the Dermatology department of ASTER, a Contract Research Organization, in Paris for 6 years, during which she led early development studies.
​
With her many years in health care and pharmaceutical industry, Anne has noted that her strengths lie in leadership and expertise in drug development. She is an alumna of the Novartis Executive Female Leadership Program and would like to be known as a leader in Dermatology research who brings innovative therapies to the market.